All Stories

  1. Blood flow in the human cerebral cortex: Large-scale pial vascularization and 1D simulation
  2. Measurement of carotid plaque burden
  3. Potential effects of probiotics on atherosclerosis
  4. Cost‐Utility Analysis of Low‐Dose Pioglitazone in a Population With Prediabetes and a History of Stroke or Transient Ischemic Attack
  5. Letter to the Editor From Spence: [Prevalence and Characteristics of Low-Renin Hypertension in a Primary Care Population]
  6. Homocysteine and Myocardial Injury
  7. Correspondence on: “Subclinical atherosclerosis: More data – More insights into prevention”
  8. Reducing Cardiovascular Risk: The Potential of Plant-Based Meat Alternatives and Egg Substitutes
  9. Poor Results with “Best Medical Therapy” in Patients with Asymptomatic Carotid Stenosis
  10. Vessel Wall Volume and Plaque Volume Should Replace Carotid Intima–Media Thickness
  11. Prior-knowledge Embedded U-Net based Fully Automatic Vessel Wall Volume Measurement of the Carotid Artery in 3D Ultrasound Image
  12. Carotid Plaque Burden Is a Stronger Predictor of Cardiovascular Risk Than IMT
  13. Vertebrobasilar ischemia: Some less recognized aspects
  14. Cerebrovascular Disease, Cardiovascular Disease, and Chronic Kidney Disease: Interplays and Influences
  15. Homocysteine and Thrombophilia in Pulmonary Hypertension
  16. Cardiovascular effects of TMAO and other toxic metabolites of the intestinal microbiome
  17. Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, and Hypertension
  18. In Memoriam: Jim Toole, MD: Ahead of His Time
  19. B vitamins for NASH: use methylcobalamin, not cyanocobalamin
  20. Problem in the Recent American Heart Association Guideline on Secondary Stroke Prevention: B Vitamins to Lower Homocysteine Do Prevent Stroke
  21. Identifying High-Risk Nonstenotic Carotid Artery Disease
  22. Management of Patients with Embolic Stroke of Unknown Source: Interpreting the Evidence in the Light of Clinical Judgement
  23. Efficacy of Lower Doses of Pioglitazone after Stroke or Transient Ischemic Attack In Patients with Insulin Resistance
  24. Fasting lipids are not a good way to assess the effects of diet on cardiovascular risk
  25. How to identify which patients should not have a systolic blood pressure target of <120 mmHg
  26. Deep Learning-Based Measurement of Total Plaque Area in B-Mode Ultrasound Images
  27. Roadmap Consensus on Carotid Artery Plaque Imaging and Impact on Therapy Strategies and Guidelines: An International, Multispecialty, Expert Review and Position Statement
  28. CONNed in Pregnancy
  29. Physiological Treatment of Hypertension in Black Patients: Time for Action
  30. Sex differences in the intestinal microbiome: interactions with risk factors for atherosclerosis and cardiovascular disease
  31. Triglyceride/High‐Density Lipoprotein Cholesterol Ratio: A Clue to Metabolic Syndrome, Insulin Resistance, and Severe Atherosclerosis
  32. Renovascular Hypertension
  33. Cardiovascular Harm From Egg Yolk and Meat: More Than Just Cholesterol and Saturated Fat
  34. It's time to stop the nonsense of withholding lipid lowering therapy on account of age
  35. Measurement of carotid plaque burden: A tool for predicting and preventing dementia?
  36. Stroke Prevention: Little-Known and Neglected Aspects
  37. Reducing the Risk of Stroke in Patients with Impaired Renal Function: Nutritional Issues
  38. Stroke Prevention in Older Adults
  39. A Voxel-Based Fully Convolution Network and Continuous Max-Flow for Carotid Vessel-Wall-Volume Segmentation From 3D Ultrasound Images
  40. IMT is not atherosclerosis
  41. China Stroke Statistics 2019: a wealth of opportunities for stroke prevention
  42. Recent advances in preventing recurrent stroke
  43. New Canadian guideline is wrong to say acetylsalicylic acid is only for patients with symptomatic vascular disease
  44. Achieving blood pressure control targets in hypertensive patients of rural China – a pilot randomized trial
  45. Risk from low blood pressure in frail older adults: diastolic pressure and pulse pressure are important
  46. Stroke Prevention
  47. Interaction of smoking, hyperhomocysteinemia and metabolic syndrome with carotid atherosclerosis: A cross sectional study in 972 non-diabetic patients
  48. Traffic‐Related Air Pollution and Carotid Plaque Burden in a Canadian City With Low‐Level Ambient Pollution
  49. Impaired Renal Function and Cerebrovascular Disease
  50. Triglyceride lowering drugs: not just icosapent ethyl
  51. Adding Insight to Injury!
  52. Effect of Vitamin B12 Levels on the Association Between Folic Acid Treatment and CKD Progression: A Post Hoc Analysis of a Folic Acid Interventional Trial
  53. Lower risk of stroke with a vegetarian diet
  54. Choosing the right therapy for a patient with asymptomatic carotid stenosis
  55. Patent foramen ovale in patients with atrial fibrillation
  56. Three-dimensional ultrasound evaluation of the effects of pomegranate therapy on carotid plaque texture using locality preserving projection
  57. Interaction of serum vitamin B12 and folate with MTHFR genotypes on risk of ischemic stroke
  58. Rationale for screening selected patients for asymptomatic carotid artery stenosis
  59. Asymptomatic Carotid Stenosis: High Risk With Suboptimal Treatment
  60. Longitudinal assessment of carotid plaque texture in three-dimensional ultrasound images based on semi-supervised graph-based dimensionality reduction and feature selection
  61. Mechanisms of Stroke in COVID-19
  62. The need for clinical judgement in the application of evidence-based medicine
  63. Chili Pepper Consumption and Cardiovascular Mortality
  64. Resistant Hypertension
  65. Socioeconomic status and stroke incidence, prevalence, mortality, and worldwide burden: an ecological analysis from the Global Burden of Disease Study 2017
  66. Trimethylamine N-oxide: not just red meat—egg yolk and renal function are also important
  67. Carotid Intima–Media Thickness Versus Carotid Plaque Burden for Predicting Cardiovascular Risk
  68. Interpreting stimulated plasma renin and aldosterone to select physiologically individualized therapy for resistant hypertension: importance of the class of stimulating drugs
  69. Registration of amiloride in South Africa: Cutting the Gordian knot
  70. Statins for Primary Prevention of Cardiovascular Disease
  71. Deep learning‐based carotid media‐adventitia and lumen‐intima boundary segmentation from three‐dimensional ultrasound images
  72. Coronary calcium is not all we need: Carotid plaque burden measured by ultrasound is better
  73. Periprocedural events dominate outcomes of carotid stenting and endarterectomy
  74. Nutrition and Risk of Stroke
  75. The Importance of Blood Pressure Gradients in the Brain
  76. Antiplatelet Therapy in Ischemic Stroke and Transient Ischemic Attack
  77. Pioglitazone Therapy in Patients With Stroke and Prediabetes
  78. Blood Pressure Gradients in the Brain: Their Importance to Understanding Pathogenesis of Cerebral Small Vessel Disease
  79. Anticoagulation in patients with Embolic Stroke of Unknown Source
  80. Vitamin B12 deficiency and hyperhomocysteinaemia in outpatients with stroke or transient ischaemic attack: a cohort study at an academic medical centre
  81. Increased carotid plaque burden in patients with family medical history of premature cardiovascular events in the absence of classical risk factors
  82. Hypertension in Africa
  83. Decline in the Severity of Carotid Atherosclerosis and Associated Risk Factors From 2002 to 2014
  84. Harm With High Levels of Serum B12 in Elderly Persons
  85. Cardiovascular benefit of egg consumption is most unlikely
  86. Advances in Stroke Prevention
  87. Elevated level of lecithin:cholesterol acyltransferase (LCAT) is associated with reduced coronary atheroma burden
  88. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
  89. Data on the gut and saliva microbiota from a cohort of atherosclerosis patients determined by 16S rRNA gene sequencing
  90. Moderate Renal Impairment and Toxic Metabolites Produced by the Intestinal Microbiome: Dietary Implications
  91. Hypertension in Blacks
  92. Fractal dimension based carotid plaque characterization from three-dimensional ultrasound images
  93. Mediterranean Diet Score: Associations with Metabolic Products of the Intestinal Microbiome, Carotid Plaque Burden, and Renal Function
  94. Stroke Prevention: Editorial to accompany June issue of SVN
  95. [18F]-Fluorodeoxyglucose PET/CT imaging as a marker of carotid plaque inflammation: Comparison to immunohistology and relationship to acuity of events
  96. Egg Consumption and Cardiovascular Risk
  97. Supplemental Vitamins and Minerals for CVD Prevention and Treatment
  98. Metabolic products of the intestinal microbiome and extremes of atherosclerosis
  99. Diastolic J curve, cuff artefact and low targets for SBP
  100. Problems with polypills
  101. The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension
  102. B Vitamins for Stroke Prevention
  103. Accuracy of Cardiovascular Risk Prediction Varies by Neighborhood Socioeconomic Position
  104. Cardioembolic stroke: everything has changed
  105. Controlling resistant hypertension
  106. How to identify which patients with asymptomatic carotid stenosis could benefit from endarterectomy or stenting
  107. Effect of wine on carotid atherosclerosis in type 2 diabetes: a 2-year randomized controlled trial
  108. Diet for stroke prevention
  109. Letter by Spence Regarding Article, “Serum Potassium Is Positively Associated With Stroke and Mortality in the Large, Population-Based Malmö Preventive Project Cohort”
  110. Homocysteine Lowering with B Vitamins for Stroke Prevention—A History
  111. Hypertension in US-born vs. foreign-born African-Americans
  112. Association of homocysteine and smoking with cerebral microemboli in patients with mechanical heart valves: a transcranial Doppler study
  113. Letter by Spence Regarding Article, “Antiplatelet Regimen for Patients With Breakthrough Strokes While on Aspirin: A Systematic Review and Meta-Analysis”
  114. Systolic blood pressure targets, diastolic J curve and cuff artefact in blood pressure measurement: a note of caution
  115. Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
  116. Smoking cessation and outcome after ischemic stroke or TIA
  117. B vitamins in stroke prevention: time to reconsider
  118. Sensitive three-dimensional ultrasound assessment of carotid atherosclerosis by weighted average of local vessel wall and plaque thickness change
  119. Motor recovery beginning 23 years after ischemic stroke
  120. Cuff Artifact, J Curve, and Application of Hypertension Guidelines in the Elderly
  121. Approaching Automated 3-Dimensional Measurement of Atherosclerotic Plaque Volume ∗
  122. Recent advances in preventing stroke recurrence
  123. Blood pressure gradients in cerebral arteries: a clue to pathogenesis of cerebral small vessel disease
  124. Nutrition in Stroke Prevention
  125. Resistant Atherosclerosis
  126. Physiological Phenotyping for Personalized Therapy of Uncontrolled Hypertension in Africa
  127. Rational Medical Therapy Is the Key to Effective Cardiovascular Disease Prevention
  128. Asymptomatic carotid stenosis
  129. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
  130. [ 18 F]-NaF PET/CT Identifies Active Calcification in Carotid Plaque
  131. 3D Ultrasound for Imaging and Quantifying Carotid Ulcers
  132. Diastolic Hypotension and Myocardial Ischemia
  133. Transcranial Doppler monitoring for microemboli: a marker of a high-risk carotid plaque
  134. Carotid plaque burden is associated with higher levels of total homocysteine
  135. CADASIL accelerated by acute hypotension
  136. Hypertension in blacks
  137. High Frequency of Variants of Candidate Genes in Black Africans with Low Renin-Resistant Hypertension
  138. Effects of eplerenone on resistance to antihypertensive medication in patients with primary or secondary hyperaldosteronism
  139. Increased Coagulation With Aging: Importance of Homocysteine and Vitamin B12
  140. Henry J.M. Barnett
  141. Determinants of carotid plaque burden
  142. Folic acid supplementation and chronic kidney disease progression
  143. Re: ‘Transcranial Doppler Ultrasound Detection of Microemboli as a Predictor of Cerebral Events in Patients with Symptomatic and Asymptomatic Carotid Disease: A Systematic Review and Meta-Analysis’
  144. Intestinal Microbiome and Atherosclerosis
  145. Statins probably do not cause cataracts
  146. Folic Acid Therapy Reduces the First Stroke Risk Associated With Hypercholesterolemia Among Hypertensive Patients
  147. Editorial: Time for Earlier and More Intensive Preventive Therapy
  148. Latest Skirmishes in the Long-Term Battle Between Carotid Endarterectomy and Stenting
  149. Cryptogenic Stroke
  150. Taking care of volunteers in a stroke trial: a new assisted-management strategy
  151. Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest
  152. Transcranial Doppler is Complementary to Echocardiography for Detection and Risk Stratification of Patent Foramen Ovale
  153. Homocysteine lowering for stroke prevention: Unravelling the complexity of the evidence
  154. Recent advances in pathogenesis, assessment, and treatment of atherosclerosis
  155. Transcranial Doppler Emboli Identifies Asymptomatic Carotid Patients at High Stroke Risk: Why This Technique Should be Used More Widely
  156. Strategies for improving blood pressure control in Africa
  157. Appropriate management of asymptomatic carotid stenosis
  158. Endarterectomy vs. stenting vs. medical therapy
  159. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
  160. Endarterectomy, Stenting, or Neither for Asymptomatic Carotid-Artery Stenosis
  161. Metabolic vitamin B12 deficiency: a missed opportunity to prevent dementia and stroke
  162. Plaque Assessment in the Management of Patients with Asymptomatic Carotid Stenosis
  163. Three-Dimensional Ultrasound of Carotid Plaque
  164. Overcoming Challenges With Statin Therapy
  165. Dietary cholesterol and egg yolk should be avoided by patients at risk of vascular disease
  166. Adding carotid total plaque area to the Framingham risk score improves cardiovascular risk classification
  167. Hypertension and Stroke
  168. Definition of Best Medical Treatment in Asymptomatic and Symptomatic Carotid Artery Stenosis
  169. Management of Patients with an Asymptomatic Carotid Stenosis—Medical Management, Endovascular Treatment, or Carotid Endarterectomy?
  170. Transcranial Doppler: Uses in Stroke Prevention
  171. Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine
  172. J Curve and Cuff Artefact, and Diagnostic Inertia in Resistant Hypertension
  173. Risk of Stroke at the Time of Carotid Occlusion
  174. Review and prioritization of stroke research recommendations to address the mission of the World Stroke Organization: a call to action from the WSO Research Committee
  175. Carotid Ultrasound Phenotypes Are Biologically Distinct
  176. Letter by Spence Regarding Article, “Diet and Stroke: Recent Evidence Supporting a Mediterranean-Style Diet and Food in the Primary Prevention of Stroke”
  177. Importance of sex and gender in atherosclerosis and cardiovascular disease
  178. 3D carotid reconstructions: imaging, pathology, algorithms and pipelines
  179. Blood Pressure Control in Canada: The View From a Stroke Prevention Clinic
  180. Dilemmas in Diagnosing and Managing Hypertension: Is White Coat Hypertension Benign?
  181. Management of Asymptomatic Carotid Stenosis
  182. Statins and Cataracts: Reverse Causality?
  183. Recent advances in atrial fibrillation and stroke
  184. Aspirin for Prevention of Cardiovascular Events in Older Japanese Patients
  185. Letter by Spence Regarding Article, "Differential Effect of B-Vitamin Therapy by Antiplatelet Use on Risk of Recurrent Vascular Events After Stroke"
  186. Measurement of Carotid Plaque Burden
  187. Management of resistant hypertension
  188. Atrial Premature Beats Predict Atrial Fibrillation in Cryptogenic Stroke: Results From the EMBRACE Trial
  189. Are some diets "mass murder"? Mediterranean diet is not to blame for increased carbohydrate intake
  190. Statins and Intracerebral Hemorrhage
  191. The 99mTc-DTPA Urinary Clearance Method May Be Preferable to the Plasma Disappearance Method for Assessing Glomerular Filtration Rate in Diabetic Nephropathy
  192. Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: Rationale and design of the Insulin Resistance Intervention after Stroke Trial
  193. Risk of Vascular Disease in Premenopausal Women With Diabetes Mellitus
  194. Identifying Which Patients With Asymptomatic Carotid Stenosis Could Benefit From Intervention: Table.
  195. Recurrent Stroke and Patent Foramen Ovale
  196. Cryptogenic Stroke and Atrial Fibrillation
  197. Secular Trends in Ischemic Stroke Subtypes and Stroke Risk Factors
  198. Statins and Ischemic Stroke
  199. How far to lower blood pressure in the long term, after a stroke?
  200. Time course of atherosclerosis regression
  201. Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies
  202. Three-Dimensional Carotid Ultrasound Plaque Texture Predicts Vascular Events
  203. Arterial age as a substitute for chronological age in the AGLA risk function could improve coronary risk prediction
  204. Atrial Fibrillation in Patients with Cryptogenic Stroke
  205. Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals
  206. Pulmonary Abnormalities and Carotid Atherosclerosis in Ex-Smokers without Airflow Limitation
  207. A Single Fixed-Dose Combination for All Patients Is Bad Medicine
  208. Volume of Carotid Artery Ulceration as a Predictor of Cardiovascular Events
  209. Microhabitat Use in a Northern Peripheral Population ofApodemia mormo: Factors Beyond the Host Plant
  210. Free fatty acids to predict recurrent ischemic stroke
  211. Effects of the Intestinal Microbiome on Constituents of Red Meat and Egg Yolks: A New Window Opens on Nutrition and Cardiovascular Disease
  212. SPARKLE (Subtypes of Ischaemic Stroke Classification System), Incorporating Measurement of Carotid Plaque Burden: A New Validated Tool for the Classification of Ischemic Stroke Subtypes
  213. Carotid Stenosis
  214. Egg consumption and coronary disease: Letter to the editor regarding Chagas P, Caramori P, Galdino TP, Barcellos CS, Gomes I, Schwanke CH. Egg consumption and coronary atherosclerotic burden. Atherosclerosis 2013 August;229(2):381–4
  215. Trust between specialists and family physicians
  216. One, two and three-dimensional ultrasound measurements of carotid atherosclerosis before and after cardiac rehabilitation: preliminary results of a randomized controlled trial
  217. Intensive risk factor control in stroke prevention
  218. Retinal Vasculature: A Window on the Brain
  219. Barometer in the Storm—Carotid Artery Plaque Quantified by Three-Dimensional Ultrasound
  220. Treatment of Renal Artery Stenosis
  221. Progression of Carotid Plaque Volume Predicts Cardiovascular Events
  222. Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
  223. Why Calls for More Routine Carotid Stenting Are Currently Inappropriate: An International, Multispecialty, Expert Review and Position Statement
  224. Egg yolk consumption, smoking and carotid plaque: Reply to letters to the Editor by Sean Lucan and T Dylan Olver et al.
  225. Atherosclerosis Imaging and the Canadian Atherosclerosis Imaging Network
  226. Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50 000 individuals
  227. Migraine, Shear Stress, and Platelet Serotonin
  228. Diabetes, Intracranial Stenosis and Microemboli in Asymptomatic Carotid Stenosis
  229. Asymptomatic Carotid Stenosis
  230. Blood pressure and opera
  231. Ultrasonographic Measure of Carotid Plaque Burden
  232. B vitamin therapy for homocysteine: renal function and vitamin B12 determine cardiovascular outcomes
  233. Antihypertensive treatment can prevent stroke and cognitive decline
  234. Atrial fibrillation and stroke prevention: is warfarin still an option? Yes
  235. Effects of Aldosterone on Human Atherosclerosis: Plasma Aldosterone and Progression of Carotid Plaque
  236. Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: What Leonardo da Vinci could not see
  237. Egg yolk consumption and carotid plaque
  238. Premature Atherosclerosis Is Associated With Hypovitaminosis D and Angiotensin-Converting Enzyme Inhibitor Non-use in Lupus Patients
  239. Letter to the Editor: The ezetimibe ‘controversy' is a misunderstanding
  240. Albuminuria and risk of stroke in African Americans: A marker of uncontrolled hypertension?
  241. Statins do not cause intracerebral hemorrhage
  242. Genetics of atherosclerosis: The power of plaque burden and progression
  243. Mechanisms of Lipoprotein(a) Pathogenicity: Prothrombotic, Proatherosclerotic, or Both?
  244. Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial
  245. Lessons From Africa: The Importance of Measuring Plasma Renin and Aldosterone in Resistant Hypertension
  246. Why the US Center for Medicare and Medicaid Services Should Not Extend Reimbursement Indications for Carotid Artery Angioplasty/Stenting
  247. Pseudohypertension
  248. Why the United States Center for Medicare and Medicaid Services (CMS) should not extend reimbursement indications for carotid artery angioplasty/stenting
  249. Why the United States Center for Medicare and Medicaid Services (CMS) Should not Extend Reimbursement Indications for Carotid Artery Angioplasty/Stenting
  250. Identifying high-risk asymptomatic carotid stenosis
  251. Why the United States Center for Medicare and Medicaid Services should not extend reimbursement indications for carotid artery angioplasty/stenting
  252. Ezetimibe and Regression of Carotid Atherosclerosis
  253. Carotid plaque measurement is superior to IMT
  254. Understanding the Complexity of Homocysteine Lowering With Vitamins
  255. High-risk asymptomatic carotid stenosis: Ulceration on 3D ultrasound vs TCD microemboli
  256. Short-acting nifedipine and risk of stroke
  257. New and Emerging Weight Management Strategies for Busy Ambulatory Settings: A Scientific Statement From the American Heart Association * Endorsed by the Society of Behavioral Medicine
  258. Asymptomatic Carotid Stenosis: Identifying Patients at High Enough Risk to Warrant Endarterectomy or Stenting
  259. Influence of Noninvasive Cardiovascular Imaging in Primary Prevention
  260. Reply to Letters from Dr Maria Luz Fernandez, Eddie Vos, and Dr Niva Shapira
  261. Toward Clinical Applications of Carotid Ultrasound: Intima-Media Thickness, Plaque Area, and Three-Dimensional Phenotypes
  262. Carotid Plaque Surface Irregularity
  263. Volumetric Evaluation of Carotid Atherosclerosis Using 3-Dimensional Ultrasonic Imaging
  264. Response to Letter by Hadjiev et al
  265. 3D Carotid Ultrasound Imaging
  266. Clinical Clues to Paradoxical Embolism
  267. Effects of Lowering Homocysteine Levels With B Vitamins on Cardiovascular Disease, Cancer, and Cause-Specific MortalityMeta-analysis of 8 Randomized Trials Involving 37 485 IndividualsEffects of Lowering Homocysteine Lev...
  268. Is there a role for revascularisation in asymptomatic carotid stenosis? No
  269. Is there a role for revascularisation in asymptomatic carotid stenosis? Yes
  270. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial
  271. B-Vitamin Therapy for Diabetic Nephropathy—Reply
  272. Secondary stroke prevention
  273. Identifying high-risk patients from carotid plaque composition
  274. Asymptomatic Carotid Stenosis: Mainly a Medical Condition
  275. Physiologic Tailoring of Treatment in Resistant Hypertension
  276. Effect of B-Vitamin Therapy on Progression of Diabetic Nephropathy
  277. Treating Arteries Instead of Risk Factors: A Paradigm Change in Management of Atherosclerosis
  278. Extremes of Unexplained Variation as a Phenotype: An Efficient Approach for Genome-Wide Association Studies of Cardiovascular Disease
  279. Three-dimensional ultrasound-based texture analysis of the effect of atorvastatin on carotid atherosclerosis
  280. Dietary Intervention to Reverse Carotid Atherosclerosis
  281. The role of lipoprotein(a) in the formation of arterial plaques, stenoses and occlusions
  282. Improvement of cardiovascular risk prediction: time to review current knowledge, debates, and fundamentals on how to assess test characteristics
  283. Effects of Intensive Medical Therapy on Microemboli and Cardiovascular Risk in Asymptomatic Carotid Stenosis
  284. Three-Dimensional Carotid Ultrasound Segmentation Variability Dependence on Signal Difference and Boundary Orientation
  285. Three-dimensional Ultrasound Quantification of Intensive Statin Treatment of Carotid Atherosclerosis
  286. Treating Hypertension in Acute Ischemic Stroke
  287. Atrial fibrillation, stroke prevention therapy and aging
  288. Longitudinal Ultrasound Evaluation of Carotid Atherosclerosis in One, Two and Three Dimensions
  289. Mechanisms of thrombogenesis in atrial fibrillation
  290. Analysis of carotid lumen surface morphology using three-dimensional ultrasound imaging
  291. Nonrigid registration of three-dimensional ultrasound and magnetic resonance images of the carotid arteries
  292. Carotid Atherosclerosis and a Reduced Likelihood for Lowered Cognitive Performance in a Canadian First Nations Population
  293. Diagnosis of primary aldosteronism: for medical management, not just surgery
  294. Mesna for the Treatment of Hyperhomocysteinemia in Hemodialysis Patients
  295. Area-preserving flattening maps of 3D ultrasound carotid arteries images
  296. Cryptogenic stroke and patent foramen ovale: Clinical clues to paradoxical embolism
  297. Scan–rescan and intra-observer variability of magnetic resonance imaging of carotid atherosclerosis at 1.5 T and 3.0 T
  298. Is Carotid Intima-Media Thickness a Reliable Clinical Predictor?
  299. A “Twisting and Bending” Model-Based Nonrigid Image Registration Technique for 3-D Ultrasound Carotid Images
  300. Angiotensin inhibition in renovascular disease: A population-based cohort study
  301. The importance of distinguishing between diffuse carotid intima-media thickening and focal plaque
  302. Quantification of carotid vessel wall and plaque thickness change using 3D ultrasound images
  303. Lipoprotein(a) Is Associated Differentially With Carotid Stenosis, Occlusion, and Total Plaque Area
  304. Geometry of the Carotid Bifurcation Predicts Its Exposure to Disturbed Flow
  305. Intra-Arterial Thrombolysis of Occluded Middle Cerebral Artery by Use of Collateral Pathways in Patients with Tandem Cervical Carotid Artery/Middle Cerebral Artery Occlusion
  306. Cerebrovascular events on awakening, patent foramen ovale and obstructive sleep apnea syndrome
  307. Polypill: For Pollyanna*
  308. Mesna for Treatment of Hyperhomocysteinemia in Hemodialysis Patients: A Placebo-Controlled, Double-Blind, Randomized Trial
  309. White-Coat Hypertension Is Hypertension
  310. Nonrigid registration of carotid ultrasound and MR images using a "twisting and bending" model
  311. APPENDIX A: Carotid Endarterectomy-An Evidence-Based Review
  312. Mapping Spatial and Temporal Changes in Carotid Atherosclerosis from Three-Dimensional Ultrasound Images
  313. Role of Renin-Angiotensin System Blockade in Atherosclerotic Renal Artery Stenosis and Renovascular Hypertension
  314. Homocysteine-lowering therapy: a role in stroke prevention?
  315. Letter by Rundek et al Regarding Article, "Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis"
  316. Mesna as a Nonvitamin Intervention to Lower Plasma Total Homocysteine Concentration: Implications for Assessment of the Homocysteine Theory of Atherosclerosis
  317. Stroke prevention in the high-risk patient
  318. Plasma total homocysteine in acute stroke
  319. SU-EE-A4-01: Development of Cardiac-Gated 3-Dimensional Ultrasound Imaging of Carotid Atherosclerosis
  320. Validation of 3D Ultrasound Vessel Wall Volume: An Imaging Phenotype of Carotid Atherosclerosis
  321. New treatment options for hypertension during acute ischemic or hemorrhagic stroke
  322. Combining Multiple Approaches for the Secondary Prevention of Vascular Events After Stroke: A Quantitative Modeling Study
  323. Manual planimetric measurement of carotid plaque volume using three-dimensional ultrasound imaging
  324. Effects of non-steroidal anti-inflammatory drugs on blood pressure
  325. Hypertension Due to Central Nervous System Dysfunction
  326. Intensive management of risk factors for accelerated atherosclerosis: the role of multiple interventions
  327. Perspective on the efficacy analysis of the Vitamin Intervention for Stroke Prevention trial
  328. The Effect of Mesna on Plasma Total Homocysteine Concentration in Hemodialysis Patients
  329. 3D ultrasound analysis of carotid plaque volume and surface morphology
  330. Carotid ultrasound phenotypes in vulnerable populations
  331. Homocysteine and Stroke Prevention: Have the Trials Settled the Issue?
  332. Measurement of Intima-Media Thickness vs. Carotid Plaque: Uses in Patient Care, Genetic Research and Evaluation of New Therapies
  333. Technology Insight: ultrasound measurement of carotid plaque—patient management, genetic research and therapy evaluation
  334. A Non-Rigid Image Registration Technique for 3D Ultrasound Carotid Images using a "Twisting and Bending" Model
  335. Measuring Effects of Antiatherosclerotic Therapies
  336. Quantification of progression and regression of carotid vessel atherosclerosis using 3D ultrasound images
  337. Thiol exchange: An in vitro assay that predicts the efficacy of novel homocysteine lowering therapies
  338. Nutrition and Stroke Prevention
  339. Relationship of the metabolic syndrome to carotid ultrasound traits
  340. Po-Thur Eve General-20: A Novel Non-Invasive 3D Ultrasound Imaging Phenotype of Carotid Atherosclerosis
  341. Po-Thur Eve General-24: Non-Invasive Imaging Phenotypes of Carotid Atherosclerosis in Subjects: MRI, B-mode and 3D Ultrasound Measurements
  342. Treating Hypertension in Acute Stroke: A Better Arrow for the Quiver
  343. Lipoprotein(a): Involved in Events, but Not Burden of Atherosclerotic Disease?
  344. Folate supplementation and cardiovascular disease
  345. Quantification of carotid vessel atherosclerosis
  346. Letter to the Editor: Individualized Therapy for Hypertension
  347. Homocysteine: Call Off the Funeral
  348. 3D Ultrasound System for Analysis of Carotid Plaque Progression and Regression
  349. Tutorial in Biostatistics: Analyzing Associations between Total Plasma Homocysteine and B Vitamins Using Optimal Categorization and Segmented Regression
  350. Disparate Associations of a Functional Promoter Polymorphism in PCK1 With Carotid Wall Ultrasound Traits
  351. Vitamin Intervention for Stroke Prevention Trial: An Efficacy Analysis
  352. Absence of Microemboli on Transcranial Doppler Identifies Low-Risk Patients With Asymptomatic Carotid Stenosis
  353. Variation in the Carotid Bifurcation Geometry of Young Versus Older Adults: Implications for Geometric Risk of Atherosclerosis
  354. Erratum to “Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions” [Atherosclerosis 178(2) (2005) 319–325]
  355. Carotid endarterectomy--An evidence-based review: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
  356. 3D Ultrasound Measurement of Change in Carotid Plaque Volume: A Tool for Rapid Evaluation of New Therapies
  357. Complications of Type 2 Diabetes Among Aboriginal Canadians: Prevalence and associated risk factors
  358. A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes
  359. Vitamin B12, homocysteine and carotid plaque in the era of folic acid fortification of enriched cereal grain products
  360. Quantification of carotid plaque volume measurements using 3D ultrasound imaging
  361. Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions
  362. Anthropometric data for magnetic resonance imaging of the carotid bifurcation
  363. Carotid Ultrasound in One, Two and Three Dimensions
  364. Dimercaptosuccinic acid for the treatment of hyperhomocysteinemia in hemodialysis patients: A placebo-controlled, double-blind, randomized trial
  365. The current epidemic of primary aldosteronism
  366. Carotid intima-media thickness and cognitive decline: what does it mean for prevention of dementia?
  367. Genetic Variation in PPARG Encoding Peroxisome Proliferator-Activated Receptor   Associated With Carotid Atherosclerosis
  368. Non-Invasive Assessment of Atherosclerosis Risk
  369. 3D Ultrasound Imaging of the Carotid Arteries
  370. Preventing Dementia by Treating Hypertension and Preventing Stroke
  371. Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration
  372. Measurement of Carotid Plaque Volume by 3-Dimensional Ultrasound
  373. Noninvasive Phenotypes of Atherosclerosis: Similar Windows but Different Views
  374. Lowering Homocysteine in Patients With Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death
  375. Sex Differences in Carotid Plaque and Stenosis
  376. The Effect of Flax Seed Cultivars with Differing Content of α-Linolenic Acid and Lignans on Responses to Mental Stress
  377. Relationship Between Blood Pressure and Stroke Risk in Patients With Symptomatic Carotid Occlusive Disease
  378. Lipoprotein Lipase (LPL) Gene Variation and Progression of Carotid Artery Plaque
  379. Infection, Inflammation, and Atherosclerosis
  380. Measurement of Carotid Plaque and Effect of Vitamin Therapy for Total Homocysteine
  381. Carotid Plaque Area: A Tool for Targeting and Evaluating Vascular Preventive Therapy
  382. Treatment options for renovascular hypertension
  383. Grapefruit juice-drug interactions
  384. Reconstruction of carotid bifurcation hemodynamics and wall thickness using computational fluid dynamics and MRI
  385. Knowledge gaps
  386. Actual practice in hypertension: Implications for persistence with and effectiveness of therapy
  387. Endarterectomy or angioplasty for treatment of carotid stenosis?
  388. Homocyst(e)ine, nitrous oxide and atherosclerosis
  389. Improved Outcomes in Stroke Thrombolysis with Pre-specified Imaging Criteria
  390. Patients With Atherosclerotic Vascular Disease
  391. Vitamin Intervention for Stroke Prevention (VISP) Trial: Rationale and Design
  392. Effect of amlodipine on hemodynamic and endocrine responses to mental stress
  393. Angiotensin II antagonists for hypertension: are there differences in efficacy?
  394. Hypocholesterolemic effects of dietary citrus juices in rabbits
  395. Management of Resistant Hypertension in Patients with Carotid Stenosis: High Prevalence of Renovascular Hypertension
  396. What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 μmol/L
  397. Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition
  398. Contents of Related Journals
  399. Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema
  400. An approach to ascertain probands with a non-traditional risk factor for carotid atherosclerosis
  401. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial
  402. Effect of Usual Doses of Folate Supplementation on Elevated Plasma Homocyst(e)ine in Hemodialysis Patients: No Difference between 1 and 5 mg Daily
  403. Benefit of Carotid Endarterectomy in Patients with Symptomatic Moderate or Severe Stenosis
  404. Editorial commentary
  405. Carotid Endarterectomy Does Not Affect Long-Term Blood Pressure: Observations from the NASCET
  406. Clinical Pharmacokinetics of Fibric Acid Derivatives (Fibrates)
  407. Metabolism of Fibric Acid Derivatives
  408. Informing the public
  409. Pseudo-hypertension in the elderly: still hazy, after all these years
  410. Correspondence
  411. Grapefruit juice—terfenadine single-dose interaction: Magnitude, mechanism, and relevance*
  412. Psychological stress and the progression of carotid artery disease
  413. Erythromycin-felodipine interaction: Magnitude, mechanism, and comparison with grapefruit juice*
  414. The acetylcholinesterase oxime reactivator HI-6 in man: Pharmacokinetics and tolerability in combination with atropine
  415. Government guidelines for treatment of hypertension
  416. Prognosis for Patients Following a Transient Ischemic Attack With and Without a Cerebral Infarction on Brain CT
  417. Grapefruit Juice and Drugs
  418. Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics
  419. Grapefruit juice–felodipine interaction: Mechanism, predictability, and effect of naringin
  420. Differences in metabolism of time-release and unmodified nicotinic acid: Explanation of the differences in hypolipidemic action?
  421. Tests for renal vascular disease
  422. Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis
  423. Interaction of citrus juices with felodipine and nifedipine
  424. Intramuscular administration of iron during long-term chelation therapy with 2,3-dimercaptosuccinic acid in a man with severe lead poisoning
  425. Measurement of Atherosclerosis: Development of an Atherosclerosis Severity Index
  426. EFFECT OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON CONTROL OF HYPERTENSION BY BETA-BLOCKERS AND DIURETICS
  427. Evaluation of once daily endralazine in hypertension
  428. The arthritic patient with hypertension: Selection of an NSAID
  429. Hypertension in Acute Ischemic Strokes
  430. EFFECTS OF TRIAMTERENE AND AMILORIDE ON URINARY SEDIMENT IN HYPERTENSIVE PATIENTS TAKING HYDROCHLOROTHIAZIDE
  431. Blood Pressure Measurement in the Elderly: Correlation of Arterial Stiffness with Difference Between Intra-arterial and Cuff Pressures
  432. Spectrum of benign intracranial hypertension in children and adolescents
  433. Hemodynamic modification of aortic atherosclerosis
  434. Potassium-sparing Diuretics: Interaction with Digoxin in Elderly Men
  435. Phenytoin-Theophylline Interaction
  436. Pseudohypertension in the Elderly
  437. Vitamins and antioxidants